Search Results - "Malta, CE"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
  2. 2

    Risk factors for oral mucositis in patients with solid tumors under treatment with cetuximab: a retrospective cross-sectional study by Martins, J-O, Borges, M-M, Malta, C-E, Guerra, J-M, Crispim, A-A, Coelho, B-C, Silva, L-F, Silva, P-G

    “…This study retrospectively analyzed the risk factors for oral mucositis (OM) during cetuximab treatment. We screened patients using cetuximab and…”
    Get full text
    Journal Article
  3. 3

    Dysgeusia increases the risk for death and other side effects during antineoplastic systemic treatment for solid tumors: a cross-sectional study by Silva, P-G, Barreto, G-A, Carlos, A-C, Borges, M-M, Malta, C-E, Barbosa, J-V, Crispim, A-A, Juaçaba, S-F, Gonzaga-Silva, L-F

    “…Chemotherapy (QT) is a systemic treatment using a combination of antineoplastic drugs, orally or intravenously, that inhibit tumor growth and fast-growing…”
    Get full text
    Journal Article
  4. 4

    Risk factors for oral mucositis during chemotherapy treatment for solid tumors: a retrospective STROBE-guided study by Martins, JO, Borges, MM, Malta, CE, Carlos, AC, Crispim, AA, Moura, JF, Fernandes-Lima, IJ, Silva, PG

    “…BACKGROUNDThis study retrospectively analyzed the risk factors for transchemotherapy oral mucositis (OM). MATERIAL AND METHODSBefore each chemotherapy cycle,…”
    Get full text
    Journal Article